Dr. Michelle M Murphy-rozanski is a Philadelphia, Pennsylvania based nurse practitioner who is specialized as Family nurse. Her current practice location is 3540 Churchill Ln, Philadelphia. Patients can reach her at 215-637-2441. Dr. Michelle M Murphy-rozanski is PHD, MSN, RN, CRNP with specialization in Family and her NPI number (Unique professional ID assigned by NPPES) is 1982959193. Dr. Michelle M Murphy-rozanski delivers family-focused care which means she provides care for patients ranging from infants to the elderly and every age in between. Family Nurse Practitioner (FNP) are frequently the primary care provider for families, which means that they will not only diagnose conditions, but also treat them. FNPs perform physical exams, order diagnostic tests and procedures, diagnose and treat illness, prescribe needed medications, and teach their patients how to develop healthy lifestyles to promote health and prevent disease.
Complete Profile:
Dr. Michelle M Murphy-rozanski speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1982959193
NPI Enumeration Date:
13 Jul, 2012
NPI Last Update On:
13 Jul, 2012
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Michelle M Murphy-rozanski 3540 Churchill Ln, Philadelphia, Pennsylvania
Zip:
19114-1808
Phone Number:
215-637-2441
Patients can reach Dr. Michelle M Murphy-rozanski at 3540 Churchill Ln, Philadelphia, Pennsylvania or can call to book an appointment on 215-637-2441.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.